Xin-bao Xu
Overview
Explore the profile of Xin-bao Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu X, Chu J, Huang H, Zhang H, Liu C, Xiao M, et al.
Zhonghua Yi Xue Za Zhi
. 2012 Nov;
92(36):2542-5.
PMID: 23158794
Objective: To compare the efficacies between transjugular intrahepatic portosystemic shunt (TIPS) and portoazygos devascularization (PAD) in the treatment of portal hypertension with variceal bleeding. Methods: From December 1993 to December...
2.
Xu X, Leng X, He Z, Chen L, Zhang H, Zhang H, et al.
Zhonghua Yi Xue Za Zhi
. 2010 May;
90(12):822-5.
PMID: 20450621
Objective: To study the effects of carbon tetrachloride (CCl4)/ethanol induction upon experimental liver fibrosis and hepatic carcinogenesis of HBV transgenic mice. Methods: The wild-type mice, p21-HBx transgenic mice with integration...
3.
Xu X, He Z, Leng X, Liang Z, Peng J, Zhang H, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2010 Mar;
18(2):119-23.
PMID: 20196951
To study the effects of Smad4 on liver fibrosis and hepatocarcinogenesis in mice treated with CCl(4)/ethanol. The wild-type mice (Smad4 +/+) and the Smad4 knockout mice (Smad4 +/-) were injected...
4.
Xu X, Cai J, Leng X, Dong J, Zhu J, He Z, et al.
World J Gastroenterol
. 2005 Jul;
11(29):4552-9.
PMID: 16052687
Aim: To review the experience in surgery for 508 patients with portal hypertension and to explore the selection of reasonable operation under different conditions. Methods: The data of 508 patients...
5.
Xu X, Cai J, Dong J, He Z, Han B, Leng X
Zhonghua Gan Zang Bing Za Zhi
. 2005 Feb;
13(2):113-6.
PMID: 15727697
Objective: To evaluate the effects of portaazygous disconnection (PAD), portacaval shunt (PCS) and distal splenocaval shunt (DSCS) on the portosytemic shunting (PSS), hepatic function (HF), hepatic mitochondrial respiratory function (HMRF),...
6.
Xu X, Leng X, He Z, Liang Z, Lin K, Wei Y, et al.
Chin Med J (Engl)
. 2004 Sep;
117(8):1170-7.
PMID: 15361290
Background: Transforming growth factor-beta1 (TGF-beta1) exerts strong fibrogenic potential in culture-activated HSCs. Smad4 is a key intracellular mediator for the transforming growth factor-beta (TGF-beta) superfamily of growth factors. The aim...
7.
Xu X, Leng X, Yang X, He Z
Zhonghua Yi Xue Za Zhi
. 2004 Aug;
84(13):1122-5.
PMID: 15312519
Objective: To study obstruction of the TGF-beta(1) signal transduction by antisense RNA of Smad(4) and its effects on experimental hepatic carcinoma of mice. Methods: We used the mouse model of...
8.
Xu X, He Z, Liang Z, Leng X
Zhonghua Gan Zang Bing Za Zhi
. 2004 May;
12(5):263-6.
PMID: 15161498
Objective: To study the therapeutic effects to block the TGF-beta1 (transforming growth factor beta1) signal transduction by antisense Smad4 gene on experimental fibrotic liver. Methods: Using the rat model of...
9.
Xu X, Leng X, He Z, Liang Z, Lin K, Yu X, et al.
Zhonghua Yi Xue Za Zhi
. 2004 May;
84(7):587-91.
PMID: 15144596
Objective: To investigate the effects of antisense Smad(4) on the biological characteristics of the fat-storing cell line CFSC. Methods: Fat-storing cells of line CFSC from rat with liver fibrosis were...